Bassel Abou Saab, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 600 High Boulevard, Kenhorst, PA 19607 Phone: 610-775-2799 Fax: 610-775-3284 |
Brian R Kane, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 600 High Blvd, Kenhorst, PA 19607 Phone: 610-775-2799 Fax: 610-775-3284 |
News Archive
Celgene Corporation today announced that after consultation with the U.S. Food and Drug Administration Celgene will discontinue treatment with REVLIMID (lenalidomide) in the open-label, phase III ORIGIN trial, which enrolled 450 patients in over 100 sites in 26 countries.
Contrast-enhanced 64-MDCT that definitively reveals acute trauma to the aorta does not need confirmation from invasive catheter angiography, which saves valuable time in treating patients in trauma centers, according to a new study by researchers from the Medical University of South Carolina in Charleston.
Renal sympathetic denervation improves anxiety, depression, quality of life and stress in patients with resistant hypertension, according to research presented at ESC Congress 2012 by Dr Denise Fischer from Saarland University Hospital.
Eisai Inc. (Headquarters: Woodcliff Lake, NJ; Chairman and CEO: Hajime Shimizu), a U.S. subsidiary of Eisai Co., Ltd. (Headquarters: Tokyo; President and CEO: Haruo Naito) today announced that the U.S. Food and Drug Administration has accepted Eisai's New Drug Application for rabeprazole sodium extended-release 50 mg for the healing and maintenance of healing of erosive gastroesophageal reflux disease, and for the treatment of symptomatic GERD.
› Verified 1 days ago